![]() Financial Daily from THE HINDU group of publications Wednesday, Sep 03, 2003 |
|
|
|
|
|
Agri-Biz & Commodities
-
Animals & Livestock Corporate - Alliances & Joint Ventures Ranbaxy, Alltech join hands for dairy product Our Bureau
New Delhi , Sept. 2 RANBAXY Laboratories Ltd on Tuesday said that its Animal Health Division has signed a marketing agreement with Alltech Biotechnology (Alltech) for YeaSacc*1026 Bolus, a product in the dairy cattle segment. According to Mr Chris King, General Manager, Alltech India, the product boosts milk production by stimulating appetite, improving rumen function and results in increased milk yield and fat percentage. "YeaSacc has demonstrated excellent results in numerous local and overseas trials, and the Indian market with its high roughage inclusion in the diet, is ideally suited to benefit from this product," he said. Ranbaxy and Alltech have plans for introducing more products in a phased manner. India is the world's largest milk producer but the average Indian cattle farmer struggles with poor average milk yield and problems such as poor appetite and low fertility. The new commercial partnership between two leading companies has the potential to improve this current situation, according to a communiqué issued here today. Kentucky-based Alltech is a world leader in the animal feed additive business. With an annual turnover of around $ 200 million, Alltech is present in 74 countries directly and through representation. It is also the only non-pharma company to be listed in the Top 20 animal health care companies worldwide. Under the Animal Health Division, Ranbaxy started its exclusive strategic business unit for livestock products in 2000.
Article E-Mail :: Comment :: Syndication
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |
Copyright © 2003, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|